Europe Microfluidics Market Size & Outlook, 2023-2030
Europe microfluidics market, 2018-2030 (US$M)
Related Markets
Europe microfluidics market highlights
- The Europe microfluidics market generated a revenue of USD 9,626.3 million in 2023.
- The market is expected to grow at a CAGR of 11.4% from 2024 to 2030.
- In terms of segment, medical was the largest revenue generating technology in 2023.
- Medical is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 9,626.3 million |
| Market revenue in 2030 | USD 20,548.1 million |
| Growth rate | 11.4% (CAGR from 2023 to 2030) |
| Largest segment | Medical |
| Fastest growing segment | Medical |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Medical, Non-Medical |
| Key market players worldwide | Illumina Inc, Roche Holding AG ADR, PerkinElmer, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Abbott Laboratories, Thermo Fisher Scientific Inc, Standard BioTools Inc |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.9% of the global microfluidics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 18,147.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Microfluidics Market Scope
Microfluidics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe microfluidics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microfluidics market will help companies and investors design strategic landscapes.
Medical was the largest segment with a revenue share of 84.07% in 2023. Horizon Databook has segmented the Europe microfluidics market based on medical, non-medical covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounted for the second-largest revenue share in 2021. The country has a high demand for diagnostics with growing funding to encourage academic research. For instance, in March 2020, Eden Tech initiated the IPANEMA project, which was financed by the EU Horizon 2020 research and innovation program.
The goal of the project was to incorporate paper-based nucleic acid testing methods into microfluidics devices for enhanced biosensing applications, such as the detection of toxigenic freshwater cyanobacteria agrifood pathogen detection and tissue engineering.
In addition, in 2021, the company launched the RENOIR European project: Muscle-on-a-chip for aging, to study how inflammatory response and other factors can hamper the restoration of damaged muscle tissues, and to build a muscle-on-a-chip platform as a prototype for pharmacological assays.
Reasons to subscribe to Europe microfluidics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe microfluidics market databook
-
Our clientele includes a mix of microfluidics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe microfluidics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe microfluidics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe microfluidics market size, by country, 2018-2030 (US$M)
Europe Microfluidics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
